ST
INFI

Spot Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Spot Trading’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,134
Closed -$205K – 4421
2014
Q4 		$205K Buy
12,134
+4,215
+53% +$61.4K ﹤0.01% 2918
2014
Q3 		$106K Sell
7,919
-27,357
-78% -$326K ﹤0.01% 3495
2014
Q2 		$449K Buy
35,276
+8,622
+32% +$89.8K ﹤0.01% 2780
2014
Q1 		$317K Buy
+26,654
New +$358K ﹤0.01% 2871
2013
Q4 		– Sell
-15,903
Closed -$225K – 4392
2013
Q3 		$277K Buy
+15,903
New +$305K ﹤0.01% 2801

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Spot Trading's INFI Position: Q1 2015 in Review

Spot Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 12,134 shares — an estimated $205K sold.

Spot Trading first reported a position in INFI in Q3 2013 and held it in 5 quarters. The position peaked at $449K in Q2 2014. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

  • Spot Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Spot Trading sold 12,134 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $205K.
  • Spot Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2013 and held it in 5 quarters.
  • Spot Trading's Infinity Pharmaceuticals, Inc. position peaked at $449K in Q2 2014.
  • 141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Spot Trading's 13F filing for Q1 2015, filed 12 May 2015.